Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Abeona Therapeutics Inc.

TRADE

NASDAQ: ABEOHealthcare / Biotechnology / USA
10.45+0.24+2.35%Vol 780 5311Y Perf -37.43%
Oct 16th, 2018 16:00
BID9.68 ASK10.79
Open10.34 Previous Close10.21
Pre-Market- After-Trading10.45
 - -%  - -%
Target Price
27.86 
Analyst Rating
Strong Buy 1.00
Potencial %
166.60 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)501 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
6.40 
Earnings Date
21st Nov 2018

Today's Price Range

10.3110.62

 

52wk Range

9.6622.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Month
-25.36%
3 Months
-26.15%
6 Months
-45.85%
1 Year
-37.43%
3 Years
151.81%
5 Years
-45.63%

Quotes

Name / TickerPriceChg.Chg.%
ABEO10.450.24002.35
AAPL222.154.79002.20
GOOG1 121.2829.03002.66
MSFT111.003.40003.16
XOM81.200.38000.47
WFC53.730.49000.92
JNJ136.562.61001.95
FB158.785.26003.43
GE12.10-0.0500-0.41
JPM108.622.28002.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 20.70
Current Ratio 21.10
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -3 771.90
Leverage Ratio 1.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-881.50
EBITDA Margin-862.10
Pre-tax Profit Margin-1 959.60
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 3.10
PS Ratios 137.28
Price to Cash Flow 30.10
Price to Free Cash Flow -19.10
Cash Flow Per Share -0.56
Price to Tangible Book4.00
Book Value per Share3.36
Enterprise Value (in ths.)378 768
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-37.50
ROE last 12 Months -26.95
Return on Assets (5Y Avg) -14.13
ROA last 12 Months -25.57
Return on Capital (5Y Avg) -
ROC last 12 Months -27.79
Return on invested Capital Q -7.28
Return on invested Capital Y-20.68
Assets Turnover0.00
Receivables Turnover39.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)3 632
Revenue per Share 0.08
Revenue Growth 3 Years 18.44
Revenue Growth 5 Years -7.49
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.16-0.25-56.25
Q01 2018-0.19-0.185.26
Q04 2017-0.13-0.19-46.15
Q03 2017-0.18-0.1327.78
Q02 2017-0.13-0.21-61.54
Q01 2017-0.13-0.130.00
Q04 2016-0.13-0.19-46.15
Q03 2016-0.17-0.0852.94
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.23-35.29Negative
12/2018 QR-0.22-37.50Negative
12/2018 FY-0.88-23.94Negative
12/2019 FY-0.81-20.90Negative
Next Report Date21st Nov 2018
Estimated EPS Next Report-0.23
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume780 531
Shares Outstanding (in ths.)47 940
Trades Count4 047
Dollar Volume7 356 372
Avg. Volume885 044
Avg. Weekly Volume803 326
Avg. Monthly Volume717 257
Avg. Quarterly Volume553 650

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

80%20%

Bearish Bullish

62%38%

Bearish Bullish

68%33%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (100.00 %)
8 (88.89 %)
8 (88.89 %)
Moderate Buy
0 (0.00 %)
1 (11.11 %)
1 (11.11 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.11
Strong Buy
1.11

There are no comments yet.

News

x